On January 8, 2020 Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, is reported to present at the J.P. Morgan Healthcare Conference at the Westin St. Francis in San Francisco on Monday, January 13, 2020 (Press release, Edwards Lifesciences, JAN 8, 2020, View Source [SID1234552886]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Michael A. Mussallem, chairman and chief executive officer, is scheduled to speak to conference attendees at 11:00 a.m. PT. A live webcast of the presentation will be available to all interested parties on the Edwards Lifesciences investor relations website at View Source An archived version of the webcast will be available later that day on the Edwards investor relations website.